Regulation of Angiogenesis Discriminates Tissue Resident MSCs from Effective and Defective Osteogenic Environments
R J Cuthbert1, E Jones1, C Sanjurjo-Rodríguez1,2
1Leeds Institute of Rheumatic and Musculoskeletal Disease, University of Leeds, Leeds LS16 7PS, UK.
Journal of Clinical Medicine
|June 3, 2020
Summary
Multipotential mesenchymal stromal cells (MSCs) from non-union sites can differentiate but have altered angiogenic properties. These MSCs may contribute to immature vascular networks, impacting regenerative therapy selection.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Cell Biology
Background:
- Atrophic long bone non-union mechanisms are unclear.
- Multipotential mesenchymal stromal cells (MSCs) are crucial for bone and blood vessel formation.
- This study investigates MSCs' role in non-union tissue formation.
Purpose of the Study:
- To examine the role of multipotential mesenchymal stromal cells (MSCs) in tissue formation at atrophic long bone non-union sites.
- To compare MSCs from non-union sites with those from induced periosteum and bone marrow.
- To assess MSC differentiation potential and angiogenic influence in vitro.
Main Methods:
- Collected tissue and MSCs from non-union sites (n=20), induced periosteal (IP) membranes (n=15), and bone marrow (n=8).
- Evaluated MSC content, differentiation, and angiogenesis in vitro using flow cytometry, histology, and quantitative PCR (qPCR).
Main Results:
- Non-union MSCs exhibited comparable differentiation to bone marrow MSCs.
- Non-union tissue had more pericytes and endothelial cells, with increased, smaller blood vessels compared to IP.
- Non-union MSCs showed distinct angiogenic gene expression, unlike IP-derived MSCs which inhibited in vitro angiogenesis.
Conclusions:
- Non-union derived MSCs possess normal differentiation capacity but altered angiogenic mediation.
- Local MSCs are implicated in the immature vascular network formation at non-union sites.
- Consider MSC angiogenic support profiles for effective regenerative therapies.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
3.2K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Mesenchymal Stem Cells
5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
Stem Cell Niche
6.0K
The stem cell niche is the dynamic microenvironment where stem cells reside. Inside these niches, the cells may remain undifferentiated, undergo high self-renewal, or become lineage-specific progenitors. Stem cells coexist with other niche cells, such as stromal cells. They also interact closely with the ECM. Cell-cell and cell-matrix communication occur via adhesion molecules or soluble factors that signal the stem cells and determine their fate. Stromal cells also provide survival signals to...
6.0K
Regulation of Hematopoietic Stem Cells
3.8K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.8K


